In esophageal squamous cell carcinoma (ESCC), IL-6 released by CAFs increased the chemoresistance of ESCC to cisplatin by increasing the chemokine receptor CXCR7 expression in tumor cells through the STAT3/NF-κB axis (117). Here, STAT3 is linked to esophageal squamous cell carcinoma.